Effects of cannabinoids on capsaicin receptor activity following exposure of primary sensory neurons to inflammatory mediators

Life Sciences

Volumn 87, Issue 5-6, 2010, Pages 162-168

  Soneji, Neil D ^a   Paule, Cleoper C ^a   Mlynarczyk, Marta ^a   Nagy, Istvan ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

CB1; Nociception; Non CB1 non CB2; Pain; Transient receptor potential vanilloid type 1 ion channel; TRPV1

Indexed keywords

ANANDAMIDE; BRADYKININ; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CAPSAICIN; COBALT; CYCLIC AMP; DEXANABINOL; NERVE GROWTH FACTOR; PROSTAGLANDIN E2; RIMONABANT; VANILLOID RECEPTOR 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; COMPETITIVE INHIBITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPOSURE; HYPERALGESIA; HYPERREFLEXIA; INFLAMMATION; MALE; MEMBRANE PERMEABILITY; NONHUMAN; RAT; SENSORY NERVE CELL;

ANIMALS; ARACHIDONIC ACIDS; BRADYKININ; CAPSAICIN; CELLS, CULTURED; COBALT; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION MEDIATORS; MALE; NERVE GROWTH FACTOR; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; SENSORY RECEPTOR CELLS; TETRAHYDROCANNABINOL; TRPV CATION CHANNELS;

RATTUS;

EID: 77954952865     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.06.003     Document Type: Article

References (38)

1. Agarwal N., Pacher P., Tegeder I., Amaya F., Constantin C.E., Brenner G.J., Rubino T., Michalski C.W., Marsicano G., Monory K., Marcie K., Marian C., Batkai S., Parolaro D., Fischer M.J., Reeh P., Kunos G., Kress M., Lutz B., Woolf C.J., Kuner R. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nature Neuroscience 2007, 10(7):870-879.
2. Ahluwalia J., Urban L., Capogna M., Bevan S., Nagy I. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience 2000, 100(4):685-688.
3. Ahluwalia J., Urban L., Bevan S., Nagy I. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. The European Journal of Neuroscience 2003, 17(12):2611-2618.
4. Akopian A.N., Ruparel N.B., Patwardhan A., Hargreaves K.M. Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation. The Journal of Neuroscience 2008, 28(5):1064-1075.
5. Anand U., Otto W.R., Sanchez-Herrera D., Facer P., Yiangou Y., Korchev Y., Birch R., Benham C., Bountra C., Chessell I.P., Anand P. Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons. Pain 2008, 138(3):667-680.
6. Bhave G., Zhu W., Wang H., Brasier D.J., Oxford G.S., Gereau R.W. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 2002, 35(4):721-731.
7. Breivogel C.S., Griffin G., Di Marzo V., Martin B.R. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Molecular Pharmacology 2001, 60(1):155-163.
8. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389(6653):816-824.
9. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288(5464):306-313.
10. Cesare P., McNaughton P. A novel heat-activated current in nociceptive neurons and its sensitization by bradykinin. Proceedings of the National Academy of Sciences of the United States of America 1996, 94(26):15435-15439.
11. Charrua A., Cruz C.D., Cruz F., Avelino A. Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis. The Journal of Urology 2007, 177(4):1537-1541.
12. Davis J.B., Gray J., Gunthorpe M.J., Hatcher J.P., Davey P.T., Overend P., Harries M.H., Latcham J., Clapham C., Atkinson K., Hughes S.A., Rance K., Grau E., Harper A.J., Pugh P.L., Rogers D.C., Bingham S., Randall A., Sheardown S.A. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000, 405(6783):183-187.
13. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258(5090):1946-1949.
14. Drmota E, Greasley P, Groblewski T. Screening assays for cannabinoid-ligand type modulators. AssigneeAstraZeneca. Patent WO2004074844, 2004.
15. Ellington H.C., Cotter M.A., Cameron N.E., Ross R.A. The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats. Neuropharmacology 2002, 42(7):966-975.
16. Evans R.M., Scott R.H., Ross R.A. Multiple actions of anandamide on neonatal rat cultured sensory neurones. British Journal of Pharmacology 2004, 141(7):1223-1233.
17. Garcia D.E., Brown S., Hille B., Mackie K. Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. The Journal of Neuroscience 1998, 18(8):2834-2841.
18. Glass M., Northup J.K. Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors. Molecular Pharmacology 1999, 56(6):1362-1369.
19. Guo A., Vulchanova L., Wang J., Li X., Elde R. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. The European Journal of Neuroscience 1999, 11(3):946-958.
20. Huang C.C., Chen Y.L., Lo S.W., Hsu K.S. Activation of cAMPdependent protein kinase suppresses the presynaptic cannabinoid inhibition of glutamatergic transmission at corticostriatal synapses. Molecular Pharmacology 2002, 61(3):578-585.
21. Kobayashi K., Fukuoka T., Obata K., Yamanaka H., Dai Y., Tokunaga A., Noguchi K. Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat prISary afferent neurons with adelta/c-fibers and colocalization with trk receptors. The Journal of Comparative Neurology 2005, 493(4):596-606.
22. Liu L., Simon S.A. Capsaicin-induced currents with distinct desensitization and Ca2+ dependence in rat trigeminal ganglion cells. Journal of Neurophysiology 1996, 75(4):1503-1514.
23. Ma W., Quirion R. Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opinion on Therapeutic Targets 2007, 11(3):307-320.
24. Mahmud A., Santha P., Paule C.C., Nagy I. Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons. Neuroscience 2009, 162(4):1202-1211.
25. Marin-Burgin A., Reppenhagen S., Klusch A., Wendland J.R., Petersen M. Low-threshold heat response antagonized by capsazepine in chick sensory neurons, which are capsaicin-insensitive. The European Journal of Neuroscience 2000, 12(10):3560-3566.
26. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346(6284):561-564.
27. Michael G.J., Priestley J.V. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. The Journal of Neuroscience 1999, 19(5):1844-1854.
28. Millns P.J., Chapman V., Kendall D.A. Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones. British Journal of Pharmacology 2001, 132(5):969-971.
29. Nagy I., Pabla R., Matesz C., Dray A., Woolf C.J., Urban L. Cobalt uptake enables identification of capsaicin- and bradykinin-sensitive subpopulations of rat dorsal root ganglion cells in vitro. Neuroscience 1993, 56(1):241-246.
30. Nagy I., Paule C.C., White J.P.M. Molecular mechanisms of TRPV1-mediated pain. Neuroimmune Biology, Neurogenic Inflammation in Health and Disease 2009, 8:75-99. Elsevier, Amsterdam. I. Berczi, G. Jancso (Eds.).
31. Pertwee R.G. The pharmacology of cannabinoid receptors and their ligands: an overview. International Journal of Obesity 2006, 30(Supplement 1):13-18.
32. Pruss R.M., Akeson R.L., Racke M.M., Wilburn J.L. Agonist-activated cobalt uptake identifies divalent cation-permeable kainate receptors on neurons and glial cells. Neuron 1991, 7(3):509-518.
33. Ross R.A., Gibson T.M., Brockie H.C., Leslie M., Pashmi G., Craib S.J., Di Marzo V., Pertwee R.G. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. British Journal of Pharmacology 2001, 132(3):631-640.
34. Santha P., Jenes A., Somogyi Cs., Nagy I. The endogenous cannabinoid anandamide inhibits transient receptor potential vanilloid type 1 receptor-mediated currents in rat cultured primary sensory neurons. Acta Physiologica Hungarica 2010, 97(2):149-159.
35. Sathianathan V., Avelino A., Charrua A., Santha P., Matesz K., Cruz F., Nagy I. Insulin induces cobalt uptake in a subpopulation of rat cultured primary sensory neurons. The European Journal of Neuroscience 2003, 18(9):2477-2486.
36. Singh Tahim A., Santha P., Nagy I. Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons. Neuroscience 2005, 136(2):539-548.
37. Woolf C.J., Ma Q. Nociceptors-noxious stimulus detectors. Neuron 2007, 55(3):353-364.
38. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., Julius D., Högestätt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999, 400(6743):452-457.